In this week’s episode, Fred Goldstein and Dr. Nick van Terheyden discuss transformative technologies from the 2 Nobel Prize winners in Chemistry this year, Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing” – aka CRISPR. A technology that is revolutionizing medicine in general but also part of another initiative to detect SARS-CoV-2 using CRISPR-Cas13a and a mobile phone. Genetic editing applied to the wicked problem of rapid point of care testing that does not require a laboratory

And I discuss what you need to be thinking about for this coming season and the next Semester for colleges – hint, there’s a lot to think about in your individual context including:

Geography
Your population
Local risk factors and
Understanding test capabilities and limits

What testing protocols and methods should be applied to businesses and colleges now and into the winter and for next semester.

Using testing strategies as part of reducing risk and what factors need to be taken into account

We even touch on super spreading events and the importance of understanding not just RO but also the k dispersion factor

And a nod to the Tesla ‘Starman’ who makes it past Mars.